Menu
Back to User profile » Prof. Dr. Chong-Jen Yu
Papers published by Prof. Dr. Chong-Jen Yu:
Prognostic Value of Pace Variability, a Novel 6MWT-Derived Feature, in Patients with Chronic Obstructive Pulmonary Disease
Huang CT, Ruan SY, Lai F, Chien JY, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1555-1564
Published Date: 21 July 2023
Prediction of Mandibular Advancement Device Response Using CPAP Pressure in Different Polysomnographic Phenotypes
Lee CF, Chen YJ, Huang WC, Hou JW, Liu YT, Shih TTF, Lee PL, Yu CJ
Nature and Science of Sleep 2022, 14:517-529
Published Date: 25 March 2022
Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Cheng SL, Li YR, Huang N, Yu CJ, Wang HC, Lin MC, Chiu KC, Hsu WH, Chen CZ, Sheu CC, Perng DW, Lin SH, Yang TM, Lin CB, Kor CT, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2869-2881
Published Date: 18 October 2021
Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients
Liu CJ, Lee TF, Ruan SY, Yu CJ, Chien JY, Hsueh PR
Infection and Drug Resistance 2019, 12:1457-1467
Published Date: 30 May 2019
Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan
Ho TW, Ruan SY, Huang CT, Tsai YJ, Lai F, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3055-3063
Published Date: 2 October 2018
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:867-874
Published Date: 8 March 2018
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996
Published Date: 11 October 2017
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2477-2485
Published Date: 21 August 2017
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2775-2783
Published Date: 8 November 2016
Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey
Hang LW, Hsu JY, Chang CJ, Wang HC, Cheng SL, Lin CH, Chan MC, Wang CC, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:665-673
Published Date: 30 March 2016
COPD in Taiwan: a National Epidemiology Survey
Cheng SL, Chan MC, Wang CC, Lin CH, Wang HC, Hsu JY, Hang LW, Chang CJ, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2459-2467
Published Date: 11 November 2015
Improving tuberculosis diagnostics with biomarkers
Shu CC, Wang JY, Lee LN, Yu CJ, Luh KT
Current Biomarker Findings 2015, 5:13-19
Published Date: 7 May 2015
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
Tseng JS, Yang TY, Chen KC, Hsu KH, Yu CJ, Liao WY, Tsai CR, Tsai MH, Yu SL, Su KY, Chen JJ, Chen HY, Chang GC
OncoTargets and Therapy 2014, 7:799-805
Published Date: 23 May 2014